(Q69522093)

English

Comparison of the rates of response to ifosfamide and cyclophosphamide in primary unresectable rhabdomyosarcomas

scientific article published on 01 January 1989

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

2667790

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2667790%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 October 2019

title

Comparison of the rates of response to ifosfamide and cyclophosphamide in primary unresectable rhabdomyosarcomas (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

2667790

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2667790%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

1 reference

1 reference

J Treuner

1

1 reference

stated in

Europe PubMed Central

PubMed ID

2667790

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2667790%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 October 2019

E Koscielniak

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

2667790

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2667790%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 October 2019

M Keim

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

2667790

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2667790%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 October 2019

publication date

1 January 1989

1 reference

stated in

Europe PubMed Central

PubMed ID

2667790

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2667790%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 October 2019

published in

Cancer Chemotherapy and Pharmacology

1 reference

stated in

Europe PubMed Central

PubMed ID

2667790

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2667790%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 October 2019

volume

24 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed ID

2667790

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2667790%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 October 2019

page(s)

S48-50

1 reference

stated in

Europe PubMed Central

PubMed ID

2667790

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2667790%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 October 2019

exact match

https://scigraph.springernature.com/pub.10.1007/bf00253241

0 references

cites work

[Results of treatment of rhabdomyosarcomas (RMS) in children. A report of the Cooperative Soft Tissue Sarcoma Study (CWS-81) of the Society of Pediatric Oncology]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2667790

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of prognostic factors in rhabdomyosarcoma. Preliminary univariate and multivariate results of the Cooperative Soft Tissue Sarcoma Study (CWS-81)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2667790

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

(Q69522093)

Comparison of the rates of response to ifosfamide and cyclophosphamide in primary unresectable rhabdomyosarcomas

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)